Infectious Disease Alert
RSSArticles
-
FDA Authorizes Updated Boosters to Protect Against Omicron
Agency prepares for potential cold weather COVID-19 case spike with latest vaccine solution.
-
Is It Possible to Sway Hesitant Patients to Take the COVID-19 Vaccine?
A survey conducted in a small New York county reveals some challenges moving forward.
-
Text Messages Boosted Pediatric Flu Vaccination Rates
Personalized, interactive, educational reminders led parents to bring children for the second shot faster and at a higher rate.
-
WHO Updates Guidance on Long-Acting HIV Prophylaxis
International group suggests adding injectable cabotegravir to list of prevention tools.
-
COVID-19 Exacerbated Antimicrobial Resistance
CDC report indicates related infections and deaths rose 15% in hospitals in 2020.
-
Infectious Disease Alert Updates
How Much Should Injectable Cabotegravir for PrEP Cost? Asymptomatic COVID Infection in Healthcare Workers
-
Is There Value in Repeating Blood Cultures While the First Set Is Still Incubating?
The yield from repeat blood cultures is low, suggesting their general use in most patients should be discouraged.
-
Getting to the NBA Finals by COVID-19 Vaccine Boosting
Vaccine booster doses were highly effective in preventing infection, whether symptomatic or asymptomatic, with the omicron variant of SARS-CoV-2 in National Basketball Association players and staff.
-
Cirrhosis and Infections
Infections in patients with cirrhosis are frequent and potentially lethal, with pneumonia associated with the highest risk for mortality.
-
Influenza Vaccination Reduces the Risk of Major Cardiovascular Events
A meta-analysis of six randomized, controlled trials revealed receipt of influenza vaccination reduced the risk of major cardiovascular events compared to the unvaccinated, with 56 patients needing vaccination to prevent one event. Higher-risk patients had 45% reduced risk.